Successful use of interferon alfa-2a for persistent parvovirus B19 infection. Mogensen TH, Skouboe MK, Molle I. Lancet Infect Dis 2022 Nov 24:S1473-3099(22)00685.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mogensen TH, Skouboe MK, Molle I. Successful use of interferon alfa-2a for persistent parvovirus B19 infection. Lancet Infect Dis 2022 Nov 24:S1473-3099(22)00685.
PMID: 36436534